
Molecular Robotics builds compact medical devices for on-site diagnostics. It uses lab-on-a-chip and organ-on-a-chip systems, powered by deep learning, nanotechnology, microfluidics, paper microfluidics, and bio MEMS. The company targets pharma, hospitals, and research labs, offering AI-driven analysis and portable diagnostic apps integrated with hardware platforms. It emphasizes point-of-care testing and accessibility in resource-limited settings. The core technologies enable faster, affordable diagnostics across healthcare and drug development.

Molecular Robotics builds compact medical devices for on-site diagnostics. It uses lab-on-a-chip and organ-on-a-chip systems, powered by deep learning, nanotechnology, microfluidics, paper microfluidics, and bio MEMS. The company targets pharma, hospitals, and research labs, offering AI-driven analysis and portable diagnostic apps integrated with hardware platforms. It emphasizes point-of-care testing and accessibility in resource-limited settings. The core technologies enable faster, affordable diagnostics across healthcare and drug development.